(Q50936762)

25 March 2018

title

Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group. (English)

1 reference

25 March 2018

1 reference

White WB

1

1 reference

25 March 2018

Mehrotra DV

series ordinal

2

1 reference

25 March 2018

Black HR

series ordinal

3

1 reference

25 March 2018

Fakouhi TD

series ordinal

4

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

25 March 2018

American Journal of Cardiology

published in

1 reference

25 March 2018

volume

80

1 reference

25 March 2018

issue

4

1 reference

25 March 2018

page(s)

469-474

1 reference

25 March 2018

Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

The clinical significance of diurnal blood pressure variations. Dippers and nondippers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Methods of blood pressure determination to assess antihypertensive agents: are casual measurements enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

The pathophysiology of the onset of morning cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Diurnal variations of blood pressure and microalbuminuria in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

Cerebrovascular consequences of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900397-4

10.1016/S0002-9149(97)00397-4

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018